ATE298090T1 - Verfahren zur selektion von zellen die antikörper exprimieren - Google Patents

Verfahren zur selektion von zellen die antikörper exprimieren

Info

Publication number
ATE298090T1
ATE298090T1 AT02762376T AT02762376T ATE298090T1 AT E298090 T1 ATE298090 T1 AT E298090T1 AT 02762376 T AT02762376 T AT 02762376T AT 02762376 T AT02762376 T AT 02762376T AT E298090 T1 ATE298090 T1 AT E298090T1
Authority
AT
Austria
Prior art keywords
selecting cells
express antibodies
antibody
protein
cells
Prior art date
Application number
AT02762376T
Other languages
English (en)
Inventor
Andy Racher
Rabinder Singh
Original Assignee
Lonza Group Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Group Ag filed Critical Lonza Group Ag
Application granted granted Critical
Publication of ATE298090T1 publication Critical patent/ATE298090T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT02762376T 2001-07-27 2002-07-19 Verfahren zur selektion von zellen die antikörper exprimieren ATE298090T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118337.5A GB0118337D0 (en) 2001-07-27 2001-07-27 Method for selecting antibody expressing cells
PCT/EP2002/008054 WO2003012449A2 (en) 2001-07-27 2002-07-19 Method for selecting antibody expressing cells

Publications (1)

Publication Number Publication Date
ATE298090T1 true ATE298090T1 (de) 2005-07-15

Family

ID=9919307

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02762376T ATE298090T1 (de) 2001-07-27 2002-07-19 Verfahren zur selektion von zellen die antikörper exprimieren

Country Status (12)

Country Link
US (1) US20040219611A1 (de)
EP (1) EP1415158B1 (de)
JP (1) JP4202251B2 (de)
KR (1) KR100663687B1 (de)
CN (1) CN1296710C (de)
AT (1) ATE298090T1 (de)
CA (1) CA2454088A1 (de)
DE (1) DE60204699T2 (de)
ES (1) ES2243757T3 (de)
GB (1) GB0118337D0 (de)
PT (1) PT1415158E (de)
WO (1) WO2003012449A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050221325A1 (en) * 2002-05-22 2005-10-06 Greg Thill Detection of secreted polypeptides
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
JP4603894B2 (ja) * 2002-12-03 2010-12-22 ユセベ ファルマ ソシエテ アノニム 抗体産生細胞を同定するためのアッセイ
ATE554390T1 (de) 2003-08-20 2012-05-15 Ucb Pharma Sa Verfahren zur gewinnung von antikörpern
EP1797436A2 (de) * 2004-10-08 2007-06-20 Cedars-Sinai Medical Center Biologische mikrokugeln für verschiedene durchflusszytometrische anwendungen
CA2655511C (en) * 2005-07-01 2017-03-21 John Schrader Methods of isolating cells and generating monoclonal antibodies
EP2137308B1 (de) 2007-03-26 2016-08-03 Agenus Inc. Zelloberflächenpräsentation, screening und produktion von interessierenden proteinen
US12529164B2 (en) 2007-09-14 2026-01-20 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
JP5933894B2 (ja) 2007-09-14 2016-06-15 アディマブ， エルエルシー 合理的に設計された、合成抗体ライブラリおよびその使用
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP2196804A4 (de) * 2007-10-05 2010-09-15 Kaneka Corp Markiertes peptid mit immunglobulin-bindungsaktivität und/oder einem immunglobulinkomplex sowie verfahren zur erkennung oder überprüfung von immunglobulin mithilfe des peptids
US8637435B2 (en) * 2007-11-16 2014-01-28 Merck Sharp & Dohme Corp. Eukaryotic cell display systems
EP2263089B1 (de) * 2008-03-03 2015-01-28 GlycoFi, Inc. Oberflächenanzeige rekombinanter proteine bei niederen eukaryoten
US8067339B2 (en) 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
EP2390661B1 (de) * 2010-05-02 2015-06-24 Miltenyi Biotec GmbH Verankerungs-/Erfassungsmittel zum Auswählen oder Analysieren einer CHO-Zelle entsprechend einem Produkt, das von der CHO-Zelle sezerniert wird
KR102810907B1 (ko) 2010-07-16 2025-05-21 아디맵 엘엘씨 항체 라이브러리
CN103185803A (zh) 2011-12-31 2013-07-03 深圳迈瑞生物医疗电子股份有限公司 一种鉴定抗体敏感性和克隆细胞株的方法及试剂盒
US8921055B2 (en) * 2012-10-30 2014-12-30 Berkeley Lights, Inc. Detecting cells secreting a protein of interest
EP2925867B1 (de) 2012-11-30 2018-06-27 Larix Biosciences LLC Neuartiges screening-verfahren für zelllinien
US10526394B2 (en) 2014-04-20 2020-01-07 New / Era / Mabs Gmbh Biomolecule-releasing cell and selection thereof by means of a surface protein
CN107109423A (zh) * 2014-06-05 2017-08-29 武汉友芝友生物制药有限公司 用于生产双特异性抗体的细胞的制备和挑选
CN104833625B (zh) * 2015-06-04 2018-02-23 武汉友芝友生物制药有限公司 表达重组抗体cho细胞系稳定性的早期鉴定方法
US10222373B2 (en) 2016-02-29 2019-03-05 Rarecyte, Inc. Method to identify antigen-specific immune cells
US9395367B1 (en) 2016-02-29 2016-07-19 Rarecyte, Inc. Method to identify antigen-specific B cells for antibody development
US9442113B1 (en) 2016-02-29 2016-09-13 Rarecyte, Inc. Method to identify antigen-specific immune cells for therapeutic development
CN114450594B (zh) * 2019-09-30 2025-05-16 东京应化工业株式会社 分泌物生产细胞的筛选方法、及分泌物生产细胞的筛选试剂盒
CN114441752B (zh) * 2020-11-03 2024-11-26 中国科学院苏州纳米技术与纳米仿生研究所 一种筛选方法
CN112710833B (zh) * 2021-01-13 2023-01-31 上海交通大学 基于微管流控芯片的细胞捕获方法
US20240310375A1 (en) * 2021-03-10 2024-09-19 Sony Group Corporation Bioparticle analysis method and reagent kit for bioparticle analysis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028524A (en) * 1987-04-24 1991-07-02 Takeda Chemical Industries, Ltd. Assay for anti-pre-S antibody
CA2211322A1 (en) * 1995-01-25 1996-08-01 Murex Diagnostics Corporation Improvements to immunoassays
AU765085B2 (en) * 1998-05-11 2003-09-11 Miltenyi Biotec Gmbh Method of direct selection of antigen-specific T cells
JP4022005B2 (ja) * 1998-10-22 2007-12-12 わかもと製薬株式会社 簡易抗体検査方法及び検査用キット
JP2001059845A (ja) * 1999-08-24 2001-03-06 Fuji Photo Film Co Ltd 乾式分析方法及び乾式分析要素
GB0002539D0 (en) * 2000-02-03 2000-03-29 Lonza Biologics Plc Process for the discrimination of immunoglobulin G-producing cells from non-immunoglobulin G-producing cells
WO2002057423A2 (en) * 2001-01-16 2002-07-25 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins

Also Published As

Publication number Publication date
PT1415158E (pt) 2005-10-31
WO2003012449A2 (en) 2003-02-13
EP1415158B1 (de) 2005-06-15
KR100663687B1 (ko) 2007-01-02
ES2243757T3 (es) 2005-12-01
JP4202251B2 (ja) 2008-12-24
EP1415158A2 (de) 2004-05-06
KR20040021660A (ko) 2004-03-10
CN1545621A (zh) 2004-11-10
CN1296710C (zh) 2007-01-24
DE60204699T2 (de) 2006-05-11
DE60204699D1 (de) 2005-07-21
CA2454088A1 (en) 2003-02-13
WO2003012449A3 (en) 2003-10-23
US20040219611A1 (en) 2004-11-04
GB0118337D0 (en) 2001-09-19
JP2005526950A (ja) 2005-09-08

Similar Documents

Publication Publication Date Title
ATE298090T1 (de) Verfahren zur selektion von zellen die antikörper exprimieren
ATE459652T1 (de) Verfahren zur herstellung von antikörpern
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
DE60219321D1 (de) Einzelketten vhh antikörper aus kamelen, verfahren zur deren herstellung in einem saugetier und deren verwendungen
DE60325482D1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
WO2005072112A3 (en) Methods for producing and identifying multispecific antibodies
WO2002078524A3 (en) Translational profiling
ATE382671T1 (de) Verfahren zur herstellung von agglomeratteilchen
DE502004009142D1 (de) Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen
ATE468390T1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
EP1340981A3 (de) Antikörper zum Nachweis von Amphetamine-Derivaten
ATE372392T1 (de) Verfahren zur bestimmung der menge einer zielnukleinsäure in einer probe
DE60319599T8 (de) Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit
EP1891433A4 (de) Verfahren zur klassifizierung chemisch quervernetzter zellulärer proben unter verwendung von massenspektren
WO2001079541A8 (en) Improvements in and relating to analysis of dna samples
ATE469917T2 (de) Verfahren zur gewinnung von antikörpern
EP1645183A4 (de) Verfahren zur herstellung von immunkompetenten zellen menschlichen ursprungs
ATE363490T1 (de) Methode zur produktion monoklonaler antikörper
RU2008111144A (ru) Способы моделирования и ингибирования миграции раковых клеток
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE50107753D1 (de) Verfahren zur abtrennung von lebensfähigen säuger- oder insekten-zellen aus zellsuspensionen
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
DE602004029578D1 (de) Verfahren zur immuntherapie von tumoren
DE602005000249D1 (de) Verfahren zur Isolierung von Bakterien aus biologischen Proben
DE602004015932D1 (de) Verfahren zur bildung eines protein-mikroarraysystems

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1415158

Country of ref document: EP

REN Ceased due to non-payment of the annual fee